Cefotime 250 mg/vial is a iv/im injection product of Incepta Pharmaceuticals Ltd. that contains Cefotaxime. Cefotime is used to treat bacterial infections, including infections of the blood (septicaemia) and of the respiratory tract such as acute or chronic bronchitis, bacterial pneumonia, infected bronchiectasis and lung abscess.
There are 24 brands of Cefotaxime listed in Bangladesh. 4 of them have a lower unit price than Cefotime. The lowest listed price is Cefot 250 mg/vial IV/IM Injection at ৳ 50.15 per unit.
What is Cefotime 250 mg/vial IV/IM Injection?
Made by Incepta Pharmaceuticals Ltd., Cefotime is a iv/im injection whose active ingredient is Cefotaxime. Cefotime comes as a 250 mg/vial iv/im injection and is given by a healthcare professional. Cefotime contains Cefotimeime, a third generation cephalosporin antibiotic that works by stopping bacteria from building their cell walls, which leads to bacterial death. Use it only as your doctor directs.
Uses of Cefotime
Cefotime is used to treat bacterial infections, including infections of the blood (septicaemia) and of the respiratory tract such as acute or chronic bronchitis, bacterial pneumonia, infected bronchiectasis and lung abscess. It may be started before the exact infecting organism is identified, or when the bacteria are known to be sensitive to it. Your doctor will decide whether it is suitable for your infection.
How to use Cefotime
Cefotime comes as a powder in a vial that is made up into a solution and given as an injection into a vein or a muscle. Do not inject it yourself unless a doctor has shown you how. Cefotime is given as an injection by a healthcare professional. Cefotime 250 mg/vial iv/im injection is taken by mouth. Always follow the treatment schedule arranged by your healthcare team. Complete the course exactly as prescribed.
Side effects of Cefotime
Rarely, a serious bowel problem called pseudomembranous colitis can occur with cephalosporins; if severe diarrhoea develops, treatment should be stopped and the doctor contacted. Side effects are reported relatively infrequently and are usually mild and temporary. Changes in kidney function have been rarely seen with high doses, and high doses in patients with kidney problems may cause encephalopathy. Tell your doctor promptly about severe or persistent diarrhoea, a rash, fever or any new worrying symptom. Tell your doctor if you notice any side effect.
Safety and precautions
The dose may need to be reduced in patients with reduced urinary output due to kidney problems. The safety of Cefotimeaxime in human pregnancy has not been established, so it should not be given during pregnancy, especially in the first trimester, without carefully weighing the expected benefit against possible risks. Safety in human pregnancy has not been established, so it should not be used in pregnancy, especially the first trimester, unless the expected benefit is weighed against possible risks; it passes into breast milk. Ask your doctor first if you are pregnant, breastfeeding, or have kidney or bowel problems.
Frequently asked questions
Why is Cefotime prescribed?
Cefotime is used to treat bacterial infections, including infections of the blood (septicaemia) and of the respiratory tract such as acute or chronic bronchitis, bacterial pneumonia, infected bronchiectasis and lung abscess. It may be started before the exact infecting organism is identified, or when the bacteria are known to be sensitive to it.
How is Cefotime used?
Cefotime comes as a powder in a vial that is made up into a solution and given as an injection into a vein or a muscle. Do not inject it yourself unless a doctor has shown you how.
Can Cefotime cause side effects?
Rarely, a serious bowel problem called pseudomembranous colitis can occur with cephalosporins; if severe diarrhoea develops, treatment should be stopped and the doctor contacted. Side effects are reported relatively infrequently and are usually mild and temporary.
Who should be careful with Cefotime?
The dose may need to be reduced in patients with reduced urinary output due to kidney problems. The safety of Cefotimeaxime in human pregnancy has not been established, so it should not be given during pregnancy, especially in the first trimester, without carefully weighing the expected benefit against possible risks.
Cefotaxime is indicated for the treatment of the following infections either before the infecting organism has been identified or when caused by bacteria of established sensitivity: Septicaemia Respiratory Tract Infections such as acute or chronic bronchitis, bacterial pneumonia, infected bronchiectasis ... Read moreCefotaxime is indicated for the treatment of the following infections either before the infecting organism has been identified or when caused by bacteria of established sensitivity: Septicaemia Respiratory Tract Infections such as acute or chronic bronchitis, bacterial pneumonia, infected bronchiectasis, lung abscess and postoperative chest infections Urinary Tract Infections such as acute and chronic pyelonephritis, cystitis and asymptomatic bacteriuria Soft-tissue Infection such as cellulitis, peritonitis and wound infections Bone and Joint Infections such as osteomyelitis, septic arthritis Obstetric and gynaecological infections: such as pelvic inflammatory disease Gonorrhoea particularly when penicillin has failed or is unsuitable Other Bacterial Infections: meningitis and other sensitive infections suitable for parenteral antibiotic therapy Prophylaxis: The administration of Cefotaxime prophylactically may reduce the incidence of certain post operative infections in patients undergoing surgical procedures that are classified as contaminated or potentially contaminated or in clean operation where infection would have serious effects.
Pharmacology
Cefotaxime binds to 1 or more of the penicillin binding proteins (PBPs) which inhibit the final transpeptidation step of peptidoglycan synthesis in bacterial cell wall, thus inhibiting biosynthesis and arresting cell wall assembly resulting in bacterial cell death. Cefotaxime is a broad spectrum bactericidal 3rd generation parenteral cephalosporin antibiotic. Cefotaxime is exceptionally active against gram-negative organisms sensitive or resistant to first or second generation cephalosporins. It is similar to other cephalosporins in activity against gram-positive bacteria.
Dosage & Administration
Adults: The recommended dosage for mild to moderate infections is 1 gm every 12 hourly. However, dosage may be varied according to the severity of infection, sensitivity of causative organisms and condition of the patient. In severe infections dosage may be increased up to 12 gm daily given in 3 or 4 divided doses. For infections caused by sensitive Pseudomonas spp. daily doses of greater than 6 gm will usually be required
Children: The usual dosage range is 100-150 mg/kg/day in 2 to 4 divided doses. However, in very severe infections doses of up to 200 mg/kg/day may be required.
Neonates: The recommended dosage is 50 mg/kg/day in 2 to 4 divided doses. In severe infections 150-200 mg/kg/day, in divided doses, have been given.
Dosage in gonorrhoea: 500 mg as a single dose.
Interaction
Increased nephrotoxicity has been reported following concomitant administration of cephalosporins and aminoglycoside antibiotics.
Contraindications
Cefotaxime is contraindicated in patients who have shown hypersensitivity to cefotaxime or the cephalosporin group of antibiotics.
Side Effects
Adverse reactions to Cefotaxime have occurred relatively infrequently and have generally been mild and transient. Effects reported include candidiasis, rashes, fever, transient rises in liver transaminase and/or alkaline phosphatase and diarrhoea. As with all cephalosporins, pseudomembranous colitis may rarely occur during treatment. If this occurs the drug should be stopped and specific treatment instituted.As with other cephalosporins, changes in renal function have been rarely observed with high doses of Cefotaxime. Administration of high doses of cephalosporins particularly in patients with renal insufficiency may result in encephalopathy. Hypersensitivity reactions have been reported, these include skin rashes, drug fever and very rarely anaphylaxis.
Pregnancy & Lactation
Although studies in animals have not shown any adverse effect on the developing foetus, the safety of Cefotaxime in human pregnancy has not been established. Consequently, Cefotaxime should not be administered during pregnancy especially during first trimester, without carefully weighing the expected benefit against possible risks. Cefotaxime is excreted in the milk.
Precautions & Warnings
Cefotaxime should be prescribed with caution in individuals with a history of gastrointestinal disease, particularly colitis. Because high and prolonged antibiotic concentrations can occur from usual doses in patients with transient or persistent reduction of urinary output because of renal insufficiency, the total daily dosage should be reduced when Cefotaxime is administered to such patients. Continued dosage should be determined by degree of renal impairment, severity of infection, and susceptibility of the causative organism. There is no clinical evidence supporting the necessity of changing the dosage of Cefotaxime in patients with even profound renal dysfunction.
Storage Conditions
Store below 25°C, protected from light and moisture. Use reconstituted solution immediately. Reconstituted solution is stable for up to 24 h if stored between 2° to 8°C.
Alternative brands of Cefotaxime
Other brands with the same generic name, cheapest first.